Cancer Research UK targets top scientists

Cancer Research UK, the health research charity, in association with its commercial arm, Cancer Research Technology, is planning to hand pick "crack teams" of up to five world-leading oncology experts to work with drugmakers. The aim is to allow collaborations between scientists at different locations and the private sector to investigate potential cancer drugs. Nick Adams, director of business development at UK oncology specialist drugmaker Antisoma, said: "this development program fits well with industry's approach to harnessing the potential of scientists based at key cancer research institutes." Under the scheme, each team forms a limited company managed by CRT with up to L500,000 ($990,950) from Cancer Research UK. Successful ventures can be bought by the sponsoring drug firm.